-

ORPEA Has Taken Note of Information Published in Yesterday’s Press

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News:

ORPEA (Paris:ORP):

The Company has taken note of information published in yesterday’s press.

The information refers to acts that were previously reported by the Company to the public prosecutor's office of Nanterre in its criminal complaint against X, the filing of which was communicated to the market on 2 May 2022. This complaint was raised as a result of investigations that revealed a certain number of fraudulent activities of which the Company or its subsidiaries may have been victims.

The Company has not currently identified any material negative impact on its cash flow or real estate assets as a result of the reported fraudulent activities. The Company intends to use all means at its disposal to recover the sums of money that it may have been deprived of as a result of these fraudulent acts.

Internal measures were immediately taken to remove the persons likely to be involved in these frauds and to strengthen the Group's internal control procedures.

At this stage, the Company does not have to make a determination as to the criminal nature of the facts it has denounced, nor on the responsibility of those involved.

The Company will keep the market informed of the outcome of its criminal complaint in accordance with corporate communication best standards and in compliance with its legal and regulatory obligations.

About ORPEA (www.orpea-corp.com)

Founded in 1989, ORPEA is one of the world leaders in Dependency care (nursing homes, assisted living, post-acute and rehabilitation hospitals, mental health hospitals, home care services).

ORPEA is listed on Euronext Paris (ISIN code: FR0000184798) and is a member of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.

Contacts

Investor Relations
ORPEA
Steve Grobet
EVP Communication and Investor Relations
s.grobet@orpea.net

Benoit Lesieur
Investor Relations Director
b.lesieur@orpea.net

Investor Relations
NewCap
Dusan Oresansky
+33 (0)1 44 71 94 94
orpea@newcap.eu

Media Relations
Image 7
Charlotte Le Barbier
+33 (0)6 78 37 27 60
clebarbier@image7.fr

Caroline Simon
+33(0)6 89 87 61 24
Caroline.simon@image7.fr

ORPEA

BOURSE:ORP

Release Versions

Contacts

Investor Relations
ORPEA
Steve Grobet
EVP Communication and Investor Relations
s.grobet@orpea.net

Benoit Lesieur
Investor Relations Director
b.lesieur@orpea.net

Investor Relations
NewCap
Dusan Oresansky
+33 (0)1 44 71 94 94
orpea@newcap.eu

Media Relations
Image 7
Charlotte Le Barbier
+33 (0)6 78 37 27 60
clebarbier@image7.fr

Caroline Simon
+33(0)6 89 87 61 24
Caroline.simon@image7.fr

More News From ORPEA

emeis Announces Its Early Exit From the Accelerated Safeguard Plan

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS) announces its early exit from the accelerated safeguard plan on February 20, 2026, following the approval of its request by the Nanterre Economic Court. This early exit, achieved in record time, was made possible by: - the implementation of a major disposal plan (€2.45 billion in disposals completed or secured since mid-2022) - the strengthening of emeis S.A.'s balance sheet structure since December 18, 2025 with the raising...

emeis: Activity and revenue at the end of 2025 (unaudited)1

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS): Laurent Guillot, Chief Executive Officer: "We are proud of our performance in 2025, with results that demonstrate that we are delivering on our commitments and in line with our strategy. The recent announcement of the creation of our property company Isemia, the completion of our disposal plan and the strengthening of our balance sheet structure already allow us to anticipate an accelerated exit from the safeguard plan in r...

emeis Announces the Creation of Isemia, a Real Estate Company Dedicated to Healthcare Real Estate in Europe

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: In accordance with the agreements signed and announced on September 23, 2025, emeis (Paris:EMEIS) announces the creation of Isemia, its healthcare real estate company dedicated to healthcare real estate assets operated by the Group, with its partners Farallon Capital and TwentyTwo Real Estate. emeis has thus received €761 million from its partners, representing 62% of the last appraised value1 of the assets held by this vehicle, thereby immedia...
Back to Newsroom